Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_assertion type Assertion NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_head.
- NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_assertion description "[Using murine BaF3 cells, stably transformed with six different FGFR1 fusion genes, as well as human KG1 cells expressing activated chimeric FGFR1 and five newly established murine SCLL cell lines, we show that ponatinib (<50 nM) can effectively inhibit phosphoactivation of the fusion kinases and their downstream effectors, such as PLC?, Stat5 and Src.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_provenance.
- NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_assertion evidence source_evidence_literature NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_provenance.
- NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_assertion SIO_000772 22781593 NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_provenance.
- NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_assertion wasDerivedFrom befree-20150227 NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_provenance.
- NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_assertion wasGeneratedBy ECO_0000203 NP718109.RA2LhKEsNLgfdSX4yT15gbFZ_9BPamTW_GGS5T536Mdg4130_provenance.